First-Time-in-Human Study and Prediction of Early Bactericidal Activity for GSK3036656, a Potent Leucyl-tRNA Synthetase Inhibitor for Tuberculosis Treatment.
Antimicrobial Agents and Chemotherapy（2019）
Key words
EBA prediction,FTIH,GSK3036656,clinical trial simulations,dose escalation,dose rationale,food effect,pharmacokinetics,repeat dose,safety,single dose,tolerability,tuberculosis
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined